1 Artificial Chordae Market Overview
    1.1 Product Overview and Scope of Artificial Chordae
    1.2 Artificial Chordae Segment by Type
        1.2.1 Global Artificial Chordae Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 ePTFE Artificial Chordae
        1.2.3 Gore-Tex Artificial Chordae
    1.3 Artificial Chordae Segment by Application
        1.3.1 Global Artificial Chordae Sales Comparison by Application: (2022-2028)
        1.3.2 Mitral Regurgitation
        1.3.3 Others
    1.4 Global Artificial Chordae Market Size Estimates and Forecasts
        1.4.1 Global Artificial Chordae Revenue 2017-2028
        1.4.2 Global Artificial Chordae Sales 2017-2028
        1.4.3 Artificial Chordae Market Size by Region: 2017 Versus 2021 Versus 2028
2 Artificial Chordae Market Competition by Manufacturers
    2.1 Global Artificial Chordae Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Artificial Chordae Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Artificial Chordae Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Artificial Chordae Manufacturing Sites, Area Served, Product Type
    2.5 Artificial Chordae Market Competitive Situation and Trends
        2.5.1 Artificial Chordae Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Artificial Chordae Players Market Share by Revenue
        2.5.3 Global Artificial Chordae Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Chordae Retrospective Market Scenario by Region
    3.1 Global Artificial Chordae Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Artificial Chordae Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Artificial Chordae Market Facts & Figures by Country
        3.3.1 North America Artificial Chordae Sales by Country
        3.3.2 North America Artificial Chordae Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Artificial Chordae Market Facts & Figures by Country
        3.4.1 Europe Artificial Chordae Sales by Country
        3.4.2 Europe Artificial Chordae Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Artificial Chordae Market Facts & Figures by Region
        3.5.1 Asia Pacific Artificial Chordae Sales by Region
        3.5.2 Asia Pacific Artificial Chordae Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Artificial Chordae Market Facts & Figures by Country
        3.6.1 Latin America Artificial Chordae Sales by Country
        3.6.2 Latin America Artificial Chordae Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Artificial Chordae Market Facts & Figures by Country
        3.7.1 Middle East and Africa Artificial Chordae Sales by Country
        3.7.2 Middle East and Africa Artificial Chordae Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Artificial Chordae Historic Market Analysis by Type
    4.1 Global Artificial Chordae Sales Market Share by Type (2017-2022)
    4.2 Global Artificial Chordae Revenue Market Share by Type (2017-2022)
    4.3 Global Artificial Chordae Price by Type (2017-2022)
5 Global Artificial Chordae Historic Market Analysis by Application
    5.1 Global Artificial Chordae Sales Market Share by Application (2017-2022)
    5.2 Global Artificial Chordae Revenue Market Share by Application (2017-2022)
    5.3 Global Artificial Chordae Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 NeoChord
        6.1.1 NeoChord Corporation Information
        6.1.2 NeoChord Description and Business Overview
        6.1.3 NeoChord Artificial Chordae Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 NeoChord Artificial Chordae Product Portfolio
        6.1.5 NeoChord Recent Developments/Updates
    6.2 Edwards Lifesciences
        6.2.1 Edwards Lifesciences Corporation Information
        6.2.2 Edwards Lifesciences Description and Business Overview
        6.2.3 Edwards Lifesciences Artificial Chordae Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Edwards Lifesciences Artificial Chordae Product Portfolio
        6.2.5 Edwards Lifesciences Recent Developments/Updates
    6.3 Valgen Holding Corporation
        6.3.1 Valgen Holding Corporation Corporation Information
        6.3.2 Valgen Holding Corporation Description and Business Overview
        6.3.3 Valgen Holding Corporation Artificial Chordae Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Valgen Holding Corporation Artificial Chordae Product Portfolio
        6.3.5 Valgen Holding Corporation Recent Developments/Updates
    6.4 CoreMedic
        6.4.1 CoreMedic Corporation Information
        6.4.2 CoreMedic Description and Business Overview
        6.4.3 CoreMedic Artificial Chordae Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 CoreMedic Artificial Chordae Product Portfolio
        6.4.5 CoreMedic Recent Developments/Updates
    6.5 Babic Chord
        6.5.1 Babic Chord Corporation Information
        6.5.2 Babic Chord Description and Business Overview
        6.5.3 Babic Chord Artificial Chordae Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Babic Chord Artificial Chordae Product Portfolio
        6.5.5 Babic Chord Recent Developments/Updates
    6.6 Gore Medical
        6.6.1 Gore Medical Corporation Information
        6.6.2 Gore Medical Description and Business Overview
        6.6.3 Gore Medical Artificial Chordae Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Gore Medical Artificial Chordae Product Portfolio
        6.6.5 Gore Medical Recent Developments/Updates
    6.7 Valtech Cardio
        6.6.1 Valtech Cardio Corporation Information
        6.6.2 Valtech Cardio Description and Business Overview
        6.6.3 Valtech Cardio Artificial Chordae Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Valtech Cardio Artificial Chordae Product Portfolio
        6.7.5 Valtech Cardio Recent Developments/Updates
    6.8 Transcardiac
        6.8.1 Transcardiac Corporation Information
        6.8.2 Transcardiac Description and Business Overview
        6.8.3 Transcardiac Artificial Chordae Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Transcardiac Artificial Chordae Product Portfolio
        6.8.5 Transcardiac Recent Developments/Updates
    6.9 ChoRe
        6.9.1 ChoRe Corporation Information
        6.9.2 ChoRe Description and Business Overview
        6.9.3 ChoRe Artificial Chordae Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 ChoRe Artificial Chordae Product Portfolio
        6.9.5 ChoRe Recent Developments/Updates
    6.10 AVVIE
        6.10.1 AVVIE Corporation Information
        6.10.2 AVVIE Description and Business Overview
        6.10.3 AVVIE Artificial Chordae Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 AVVIE Artificial Chordae Product Portfolio
        6.10.5 AVVIE Recent Developments/Updates
7 Artificial Chordae Manufacturing Cost Analysis
    7.1 Artificial Chordae Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Artificial Chordae
    7.4 Artificial Chordae Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Artificial Chordae Distributors List
    8.3 Artificial Chordae Customers
9 Artificial Chordae Market Dynamics
    9.1 Artificial Chordae Industry Trends
    9.2 Artificial Chordae Market Drivers
    9.3 Artificial Chordae Market Challenges
    9.4 Artificial Chordae Market Restraints
10 Global Market Forecast
    10.1 Artificial Chordae Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Artificial Chordae by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Artificial Chordae by Type (2023-2028)
    10.2 Artificial Chordae Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Artificial Chordae by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Artificial Chordae by Application (2023-2028)
    10.3 Artificial Chordae Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Artificial Chordae by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Artificial Chordae by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Artificial Chordae Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Artificial Chordae Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Artificial Chordae Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Artificial Chordae Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Artificial Chordae Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Artificial Chordae Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Artificial Chordae Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Artificial Chordae Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Artificial Chordae Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Artificial Chordae Manufacturing Sites and Area Served
    Table 11. Manufacturers Artificial Chordae Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Artificial Chordae by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Chordae as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Artificial Chordae Sales by Region (2017-2022) & (K Units)
    Table 16. Global Artificial Chordae Sales Market Share by Region (2017-2022)
    Table 17. Global Artificial Chordae Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Artificial Chordae Revenue Market Share by Region (2017-2022)
    Table 19. North America Artificial Chordae Sales by Country (2017-2022) & (K Units)
    Table 20. North America Artificial Chordae Sales Market Share by Country (2017-2022)
    Table 21. North America Artificial Chordae Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Artificial Chordae Revenue Market Share by Country (2017-2022)
    Table 23. Europe Artificial Chordae Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Artificial Chordae Sales Market Share by Country (2017-2022)
    Table 25. Europe Artificial Chordae Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Artificial Chordae Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Artificial Chordae Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Artificial Chordae Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Artificial Chordae Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Artificial Chordae Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Artificial Chordae Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Artificial Chordae Sales Market Share by Country (2017-2022)
    Table 33. Latin America Artificial Chordae Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Artificial Chordae Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Artificial Chordae Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Artificial Chordae Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Artificial Chordae Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Artificial Chordae Revenue Market Share by Country (2017-2022)
    Table 39. Global Artificial Chordae Sales by Type (2017-2022) & (K Units)
    Table 40. Global Artificial Chordae Sales Market Share by Type (2017-2022)
    Table 41. Global Artificial Chordae Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Artificial Chordae Revenue Share by Type (2017-2022)
    Table 43. Global Artificial Chordae Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Artificial Chordae Sales (K Units) by Application (2017-2022)
    Table 45. Global Artificial Chordae Sales Market Share by Application (2017-2022)
    Table 46. Global Artificial Chordae Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Artificial Chordae Revenue Share by Application (2017-2022)
    Table 48. Global Artificial Chordae Price by Application (2017-2022) & (US$/Unit)
    Table 49. NeoChord Corporation Information
    Table 50. NeoChord Description and Business Overview
    Table 51. NeoChord Artificial Chordae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. NeoChord Artificial Chordae Product
    Table 53. NeoChord Recent Developments/Updates
    Table 54. Edwards Lifesciences Corporation Information
    Table 55. Edwards Lifesciences Description and Business Overview
    Table 56. Edwards Lifesciences Artificial Chordae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Edwards Lifesciences Artificial Chordae Product
    Table 58. Edwards Lifesciences Recent Developments/Updates
    Table 59. Valgen Holding Corporation Corporation Information
    Table 60. Valgen Holding Corporation Description and Business Overview
    Table 61. Valgen Holding Corporation Artificial Chordae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Valgen Holding Corporation Artificial Chordae Product
    Table 63. Valgen Holding Corporation Recent Developments/Updates
    Table 64. CoreMedic Corporation Information
    Table 65. CoreMedic Description and Business Overview
    Table 66. CoreMedic Artificial Chordae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. CoreMedic Artificial Chordae Product
    Table 68. CoreMedic Recent Developments/Updates
    Table 69. Babic Chord Corporation Information
    Table 70. Babic Chord Description and Business Overview
    Table 71. Babic Chord Artificial Chordae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Babic Chord Artificial Chordae Product
    Table 73. Babic Chord Recent Developments/Updates
    Table 74. Gore Medical Corporation Information
    Table 75. Gore Medical Description and Business Overview
    Table 76. Gore Medical Artificial Chordae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Gore Medical Artificial Chordae Product
    Table 78. Gore Medical Recent Developments/Updates
    Table 79. Valtech Cardio Corporation Information
    Table 80. Valtech Cardio Description and Business Overview
    Table 81. Valtech Cardio Artificial Chordae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Valtech Cardio Artificial Chordae Product
    Table 83. Valtech Cardio Recent Developments/Updates
    Table 84. Transcardiac Corporation Information
    Table 85. Transcardiac Description and Business Overview
    Table 86. Transcardiac Artificial Chordae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Transcardiac Artificial Chordae Product
    Table 88. Transcardiac Recent Developments/Updates
    Table 89. ChoRe Corporation Information
    Table 90. ChoRe Description and Business Overview
    Table 91. ChoRe Artificial Chordae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. ChoRe Artificial Chordae Product
    Table 93. ChoRe Recent Developments/Updates
    Table 94. AVVIE Corporation Information
    Table 95. AVVIE Description and Business Overview
    Table 96. AVVIE Artificial Chordae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. AVVIE Artificial Chordae Product
    Table 98. AVVIE Recent Developments/Updates
    Table 99. Production Base and Market Concentration Rate of Raw Material
    Table 100. Key Suppliers of Raw Materials
    Table 101. Artificial Chordae Distributors List
    Table 102. Artificial Chordae Customers List
    Table 103. Artificial Chordae Market Trends
    Table 104. Artificial Chordae Market Drivers
    Table 105. Artificial Chordae Market Challenges
    Table 106. Artificial Chordae Market Restraints
    Table 107. Global Artificial Chordae Sales Forecast by Type (2023-2028) & (K Units)
    Table 108. Global Artificial Chordae Sales Market Share Forecast by Type (2023-2028)
    Table 109. Global Artificial Chordae Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 110. Global Artificial Chordae Revenue Market Share Forecast by Type (2023-2028)
    Table 111. Global Artificial Chordae Sales Forecast by Application (2023-2028) & (K Units)
    Table 112. Global Artificial Chordae Sales Market Share Forecast by Application (2023-2028)
    Table 113. Global Artificial Chordae Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 114. Global Artificial Chordae Revenue Market Share Forecast by Application (2023-2028)
    Table 115. Global Artificial Chordae Sales Forecast by Region (2023-2028) & (K Units)
    Table 116. Global Artificial Chordae Sales Market Share Forecast by Region (2023-2028)
    Table 117. Global Artificial Chordae Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 118. Global Artificial Chordae Revenue Market Share Forecast by Region (2023-2028)
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Artificial Chordae
    Figure 2. Global Artificial Chordae Market Share by Type in 2021 & 2028
    Figure 3. ePTFE Artificial Chordae Product Picture
    Figure 4. Gore-Tex Artificial Chordae Product Picture
    Figure 5. Global Artificial Chordae Market Share by Application in 2021 & 2028
    Figure 6. Mitral Regurgitation
    Figure 7. Others
    Figure 8. Global Artificial Chordae Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Artificial Chordae Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Artificial Chordae Sales (2017-2028) & (K Units)
    Figure 11. Artificial Chordae Sales Share by Manufacturers in 2021
    Figure 12. Global Artificial Chordae Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Artificial Chordae Players: Market Share by Revenue in 2021
    Figure 14. Artificial Chordae Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Artificial Chordae Sales Market Share by Region (2017-2022)
    Figure 16. Global Artificial Chordae Sales Market Share by Region in 2021
    Figure 17. Global Artificial Chordae Revenue Market Share by Region (2017-2022)
    Figure 18. Global Artificial Chordae Revenue Market Share by Region in 2021
    Figure 19. United States Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Artificial Chordae Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Artificial Chordae by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Artificial Chordae
    Figure 43. Manufacturing Process Analysis of Artificial Chordae
    Figure 44. Artificial Chordae Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed